Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TriSalus Life Sciences In...

    NASDAQ: TLSI · Real-Time Price · USD
    5.32
    0.25 (4.93%)
    At close: Jun 27, 2025, 3:59 PM
    5.32
    0.00%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    TriSalus Life Sciences Statistics

    Share Statistics

    TriSalus Life Sciences has 37.98M shares outstanding. The number of shares has increased by 12.27% in one year.

    Shares Outstanding

    n/a
    		 37.98M

    Shares Change (YoY)

    n/a
    		 12.27%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 8.85%

    Shares Floating

    n/a
    		 15.89M

    Failed to Deliver (FTD) Shares

    n/a
    		 229

    FTD / Avg. Volume

    n/a
    		 0.5%

    Short Selling Information

    The latest short interest is 119.69K, so 0.32% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 119.69K

    Short % of Shares Out

    n/a
    		 0.32%

    Short % of Float

    n/a
    		 0.49%

    Short Ratio (days to cover)

    n/a
    		 3.42

    Valuation Ratios

    The PE ratio is -4 and the forward PE ratio is -30. TriSalus Life Sciences's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -4

    Forward PE

    n/a
    		 -30

    PS Ratio

    n/a
    		 4.51

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 -5.13

    P/FCF Ratio

    n/a
    		 -3.22

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for TriSalus Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.02, with a Debt / Equity ratio of -0.91.

    Current Ratio

    n/a
    		 2.02

    Quick Ratio

    n/a
    		 1.63

    Debt / Equity

    n/a
    		 -0.91

    Debt / EBITDA

    n/a
    		 -0.65

    Debt / FCF

    n/a
    		 -0.57

    Interest Coverage

    n/a
    		 -11.7

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $267,554.55

    Profits Per Employee

    n/a
    		 $-302,118.18

    Employee Count

    n/a
    		 110

    Asset Turnover

    n/a
    		 1.23

    Inventory Turnover

    n/a
    		 1.01

    Taxes

    Income Tax

    n/a
    		 6K

    Effective Tax Rate

    n/a
    		 -0.02%

    Stock Price Statistics

    The stock price has increased by -3.62% in the last 52 weeks. The beta is 0.47, so TriSalus Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.47

    52-Week Price Change

    n/a
    		 -3.62%

    50-Day Moving Average

    n/a
    		 5.35

    200-Day Moving Average

    n/a
    		 4.93

    Relative Strength Index (RSI)

    n/a
    		 50.02

    Average Volume (20 Days)

    n/a
    		 46,261

    Income Statement

    In the last 12 months, TriSalus Life Sciences had revenue of 29.43M and earned -33.23M in profits. Earnings per share was -1.25.

    Revenue

    n/a
    		 29.43M

    Gross Profit

    n/a
    		 25.33M

    Operating Income

    n/a
    		 -36.16M

    Net Income

    n/a
    		 -33.23M

    EBITDA

    n/a
    		 -36.16M

    EBIT

    n/a
    		 -33.13M

    Earnings Per Share (EPS)

    n/a
    		 -1.25
    Full Income Statement

    Balance Sheet

    The company has 8.53M in cash and 23.63M in debt, giving a net cash position of -15.1M.

    Cash & Cash Equivalents

    n/a
    		 8.53M

    Total Debt

    n/a
    		 23.63M

    Net Cash

    n/a
    		 -15.1M

    Retained Earnings

    n/a
    		 -279.55M

    Total Assets

    n/a
    		 28.63M

    Working Capital

    n/a
    		 13.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -40.84M and capital expenditures -345K, giving a free cash flow of -41.19M.

    Operating Cash Flow

    n/a
    		 -40.84M

    Capital Expenditures

    n/a
    		 -345K

    Free Cash Flow

    n/a
    		 -41.19M

    FCF Per Share

    n/a
    		 -1.55
    Full Cash Flow Statement

    Margins

    Gross margin is 86.06%, with operating and profit margins of -122.88% and -112.92%.

    Gross Margin

    n/a
    		 86.06%

    Operating Margin

    n/a
    		 -122.88%

    Pretax Margin

    n/a
    		 -102.07%

    Profit Margin

    n/a
    		 -112.92%

    EBITDA Margin

    n/a
    		 -122.88%

    EBIT Margin

    n/a
    		 -122.88%

    FCF Margin

    n/a
    		 -139.95%

    Dividends & Yields

    TLSI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TLSI is $11, which is 106.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $11

    Price Target Difference

    n/a
    		 106.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -13.25

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist